The Efficacy, Safety, and Cost Benefit of Olanzapine versus Aprepitant in Highly Emetogenic Chemotherapy: A Pilot Study from South India

Background. The efficacy, safety, and cost benefit of olanzapine (OLN) when compared to aprepitant (APR) in the prevention of chemotherapy induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC) were evaluated. Methods. A prospective pilot study was done in chem...

Descripción completa

Detalles Bibliográficos
Autores principales: Babu, Govind, Saldanha, Smitha Carol, Kuntegowdanahalli Chinnagiriyappa, Lakshmaiah, Jacob, Linu Abraham, Mallekavu, Suresh Babu, Dasappa, Loknatha, Kiran, Pretesh Rohan, Sreevatsa, Aparna, Appachu, Sandhya, Unnikrishnan, Vineetha, Arroju, Venugopal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748067/
https://www.ncbi.nlm.nih.gov/pubmed/26925265
http://dx.doi.org/10.1155/2016/3439707

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748067/
https://www.ncbi.nlm.nih.gov/pubmed/26925265
http://dx.doi.org/10.1155/2016/3439707

Ejemplares similares